Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777851
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2021-02-25
Brief Title:
Regorafenib-pembrolizumab vs TACETARE in Intermediate Stage HCC Beyond Up-to-7
Sponsor:
Organization:
Translational Research in Oncology